Cost effectiveness of adding budesonide/formoterol to tiotropium in COPD in four Nordic countries

Rune Nielsen; Hannu Kankaanranta; Leif Bjermer; Peter Lange; Sofie Arnetorp; Morten Hedegaard; Anna Stenling; Nicole Mittmann

doi:10.1016/j.rmed.2013.06.007

Cost effectiveness of adding budesonide/formoterol to tiotropium in COPD in four Nordic countries

Rune Nielsen, Hannu Kankaanranta, Leif Bjermer, Peter Lange, Sofie Arnetorp, Morten Hedegaard, Anna Stenling, Nicole Mittmann

7 Citationer (Scopus)

Abstract

Assess the cost effectiveness of budesonide/formoterol (BUD/FORM) Turbuhaler(®)+tiotropium (TIO) HandiHaler(®) vs. placebo (PBO)+TIO in patients with chronic obstructive pulmonary disease (COPD) eligible for inhaled corticosteroids/long-acting β2-agonists (ICS/LABA).

Originalsprog	Engelsk
Tidsskrift	Respiratory medicine
Vol/bind	107
Udgave nummer	11
Sider (fra-til)	1709-21
Antal sider	13
ISSN	0954-6111
DOI	https://doi.org/10.1016/j.rmed.2013.06.007
Status	Udgivet - nov. 2013

Adgang til dokumentet

10.1016/j.rmed.2013.06.007

Citationsformater

@article{02b0e172315b4725b2b52b9f8221fb8a,

title = "Cost effectiveness of adding budesonide/formoterol to tiotropium in COPD in four Nordic countries",

abstract = "Assess the cost effectiveness of budesonide/formoterol (BUD/FORM) Turbuhaler({\textregistered})+tiotropium (TIO) HandiHaler({\textregistered}) vs. placebo (PBO)+TIO in patients with chronic obstructive pulmonary disease (COPD) eligible for inhaled corticosteroids/long-acting β2-agonists (ICS/LABA).",

author = "Rune Nielsen and Hannu Kankaanranta and Leif Bjermer and Peter Lange and Sofie Arnetorp and Morten Hedegaard and Anna Stenling and Nicole Mittmann",

year = "2013",

month = nov,

doi = "10.1016/j.rmed.2013.06.007",

language = "English",

volume = "107",

pages = "1709--21",

journal = "Respiratory medicine",

issn = "0954-6111",

publisher = "W.B. Saunders Ltd",

number = "11",

}

TY - JOUR

T1 - Cost effectiveness of adding budesonide/formoterol to tiotropium in COPD in four Nordic countries

AU - Nielsen, Rune

AU - Kankaanranta, Hannu

AU - Bjermer, Leif

AU - Lange, Peter

AU - Arnetorp, Sofie

AU - Hedegaard, Morten

AU - Stenling, Anna

AU - Mittmann, Nicole

PY - 2013/11

Y1 - 2013/11

N2 - Assess the cost effectiveness of budesonide/formoterol (BUD/FORM) Turbuhaler(®)+tiotropium (TIO) HandiHaler(®) vs. placebo (PBO)+TIO in patients with chronic obstructive pulmonary disease (COPD) eligible for inhaled corticosteroids/long-acting β2-agonists (ICS/LABA).

AB - Assess the cost effectiveness of budesonide/formoterol (BUD/FORM) Turbuhaler(®)+tiotropium (TIO) HandiHaler(®) vs. placebo (PBO)+TIO in patients with chronic obstructive pulmonary disease (COPD) eligible for inhaled corticosteroids/long-acting β2-agonists (ICS/LABA).

U2 - 10.1016/j.rmed.2013.06.007

DO - 10.1016/j.rmed.2013.06.007

M3 - Journal article

C2 - 23856511

SN - 0954-6111

VL - 107

SP - 1709

EP - 1721

JO - Respiratory medicine

JF - Respiratory medicine

IS - 11

ER -

Cost effectiveness of adding budesonide/formoterol to tiotropium in COPD in four Nordic countries

Abstract

Adgang til dokumentet

Fingeraftryk

Citationsformater